Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through ...

In this article, we are going to take a look at where Bio-Rad Laboratories, Inc. (NYSE:BIO) stands against the other medical technology stocks. The MedTech sector is crucial in healthcare ...

Low commission rates start at $0 for U.S. listed stocks & ETFs*. Margin loan rates from 4.83% to 5.83%. Commission-free trading on stocks & ETFs. Earn $+0.06 per options contract and 5.1% APY on ...

Cibc World Markets Corp reduced its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 24.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities ...

In a report released yesterday, Tycho Peterson from Jefferies maintained a Hold rating on Bio-Rad Laboratories (BIO – Research Report), with a ...

In trading on Monday, shares of Bio-Rad Laboratories Inc (Symbol: BIO) entered into oversold territory, hitting an RSI reading of 29.9, after changing hands as low as $251.04 per share.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of Foresight™ Pro 45 cm inner diameter (ID) ...

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...